Radiation-associated pneumonitis following autologous stem cell transplantation: Predictive factors, disease characteristics and treatment outcomes

Bone Marrow Transplantation

Volumn 27, Issue 2, 2001, Pages 177-182

  Chen, C I ^a   Abraham, R ^a   Tsang, R ^a   Crump, M ^a   Keating, A ^a   Stewart, A K ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autotransplant; Myeloma; Pneumonitis; Pulmonary; Radiation; TBI

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 MICROGLOBULIN; BUSULFAN; C REACTIVE PROTEIN; CARMUSTINE; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; MELPHALAN; METHOTREXATE; PREDNISONE; STEROID; VINCRISTINE;

ADULT; AGE; ANEMIA; ARTICLE; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GENDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERSTITIAL PNEUMONIA; LUNG DISEASE; LUNG FUNCTION; LUNG TOXICITY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; PREDICTION; PRIORITY JOURNAL; RADIATION PNEUMONIA; SMOKING; STEM CELL TRANSPLANTATION; SURVIVAL; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIATION PNEUMONITIS; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0035131317     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702771     Document Type: Article

References (40)

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
2. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
3. Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/autotransplantation and who were conventionally treated
4. Autologous stem cell transplantation in multiple myeloma: Results of the European group for bone marrow transplantation
5. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French registry on autologous transplantation in multiple myeloma
6. Pulmonary complications of marrow transplantation. Review of the Seattle experience
7. Pulmonary complications occurring after allogeneic bone marrow transplantation
8. A comparison of single-dose and fractionated total-body irradiation on the development of pneumonitis following bone marrow transplantation
9. High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma
10. Thiotepa, busulfan, and cyclophosphamide: A new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma
11. Autologous peripheral blood stem cell transplantation for multiple myeloma: A report of 259 cases from the Spanish registry
12. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma
13. Transplantation in patients with multiple myeloma: A multicenter comparative analysis of peripheral blood stem cell and allogeneic transplant
14. Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma
15. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclo-phosphamide
16. Autografting for multiple myeloma: A 5-year experience at a single institution
17. Interstitial pneumonitis following autologous bone marrow transplantation
18. Interstitial pneumonitis following autologous transplantation
19. Difference in posttransplant recovery of immune reactivity between allogeneic and autologous bone marrow transplantation
20. Pulmonary complications of bone marrow transplantation: A comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide
21. Pulmonary radiation injury
22. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients
23. Idiopathic interstitial pneumonia following bone marrow transplantation: The relationship with total body irradiation
24. Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma
25. Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma
26. Iron-deficiency anaemia: Its effect on transfer for the lung (diffusing capacity) and ventilation and cardiac frequency during sub-maximal exercise
27. Statistical methods for rates and proportions
28. Nonparametric estimation from incomplete observations
29. Asymptomatically efficient rank invariant test procedures
30. Acute and chronic pulmonary complications following autologous bone marrow transplantation in non-Hodgkin's lymphoma
31. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors
32. The interaction of drug and radiation effects on normal tissues
33. Drug-induced lung disease
34. Cyclophosphamide 24 hours before or after total body irradiation: Effects on lung and bone marrow
35. Esophageal-pulmonary toxicity from concomitant use of adriamycin and irradiation
36. Melphalan-induced pulmonary interstitial fibrosis
37. Pulmonary histopathologic changes associated with melphalan therapy
38. High dose melphalan with autologous bone marrow transplantation. Treatment of poor prognosis tumors
39. High-dose melphalan for multiple myeloma: Long-term follow-up data
40. Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: Relationship to total body irradiation and graft-versus-host disease